Clinical Trials · NCT07468552
Trial of Tirzepatide for the Treatment of Cannabis Use Disorder
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Enrollment
- 100
- Start date
- Nov 2026
- Locations
- See registry
- Primary endpoint
- Maximum Tolerated Dose (MTD)